Neurodermatitis aggravated and Malaise

Summary:

Malaise is found among people with Neurodermatitis aggravated, especially for people who are female, 60+ old.

The study analyzes which people have Malaise with Neurodermatitis aggravated. It is created by eHealthMe based on reports of 63 people who have Neurodermatitis aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Neurodermatitis aggravated?

Neurodermatitis aggravated (a skin disorder characterized by long lasting itching and scratching) is found to be associated with 311 drugs and 104 conditions by eHealthMe. Check the latest studies of Neurodermatitis aggravated.

What is Malaise?

Malaise (a feeling of general discomfort or uneasiness) is found to be associated with 3,514 drugs and 5,119 conditions by eHealthMe. Check the latest studies of Malaise.

On Jul, 15, 2026

63 people who have Neurodermatitis Aggravated and Malaise are studied.

Would you have Malaise when you have Neurodermatitis aggravated?

Gender of people who have Neurodermatitis Aggravated and experienced Malaise *:

female: 77.05 %
male: 22.95 %

Age of people who have Neurodermatitis Aggravated and experienced Malaise *:

Common co-existing conditions for these people *:

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 13 people, 20.63%
Asthma: 7 people, 11.11%
Diabetes: 3 people, 4.76%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 4.76%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 2 people, 3.17%
Osteoporosis (bones weak and more likely to break): 2 people, 3.17%
Gastric Ulcer (stomach ulcer): 2 people, 3.17%
Urination - Excessive Volume: 1 person, 1.59%
High Blood Cholesterol: 1 person, 1.59%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 1.59%

Common drugs taken by these people *:

Dupixent: 51 people, 80.95%
Mometasone Furoate: 3 people, 4.76%
Singulair: 3 people, 4.76%
Rinvoq: 3 people, 4.76%
Gabapentin: 3 people, 4.76%
Keflex: 2 people, 3.17%
Proair Hfa: 2 people, 3.17%
Prednisone: 2 people, 3.17%
Clindamycin Hydrochloride: 2 people, 3.17%
Enbrel: 2 people, 3.17%

Common symptoms for these people *:

Itching: 9 people, 14.29%
Rashes (redness): 8 people, 12.70%
Weakness: 5 people, 7.94%
Nausea (feeling of having an urge to vomit): 5 people, 7.94%
Headache (pain in head): 4 people, 6.35%
Pain: 4 people, 6.35%
Hypersensitivity: 4 people, 6.35%
Dyspnea (difficult or laboured breathing): 3 people, 4.76%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 3 people, 4.76%
Fatigue (feeling of tiredness): 3 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Malaise?

- Check whether Malaise is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Neurodermatitis aggravated (5 reports)
Malaise (529,933 reports)

All the drugs that are associated with Malaise:

Malaise (3,514 drugs)

All the conditions that are associated with Malaise:

Malaise (5,119 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Malaise and Neurodermatitis aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.